Home > Healthcare > Medical Devices > Diagnostic Devices > Non-invasive Helicobacter Pylori Testing Market

Non-invasive Helicobacter Pylori Testing Market Size

Report ID: GMI9134
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Non-invasive Helicobacter Pylori Testing Market Size

Non-invasive helicobacter pylori testing market size was valued at around USD 273.6 million in 2023 and is estimated to grow at 7.1% CAGR from 2024 to 2032. The rising prevalence of gastric and duodenal illnesses, such as gastric cancer and peptic ulcer disease, is driving the demand for non-invasive Helicobacter Pylori (H. pylori) testing. H. pylori infection is a significant risk factor for these conditions, and non-invasive testing is often used as the first line of treatment for H. pylori infections.

To get key market trends

Download Free Sample

According to data reported by American Cancer Society, approximately 26,890 new cases of stomach cancer are diagnosed each year in the U.S. including 16,160 cases in men and 10,730 cases in women. Furthermore, non-invasive methods are increasingly being used for the diagnosis of helicobacter pylori infections, particularly in children. High throughput diagnostic systems are being developed for local diagnostic testing, which can provide quick and accurate results.

Non-invasive Helicobacter Pylori Testing Market Report Attributes
Report Attribute	Details
Base Year:	2023
Non-invasive Helicobacter Pylori Testing Market Size in 2023:	USD 273.6 Million
Forecast Period:	2024 - 2032
Forecast Period 2024 - 2032 CAGR:	7.1%
2032 Value Projection:	USD 508.1 Million
Historical Data for:	2021 - 2023
No. of Pages:	105
Tables, Charts & Figures:	118
Segments covered:	Test Type, Method, End-use and Region
Growth Drivers:	Rising prevalence of gastric and duodenal illnesses Increasing need for effective anti-microbial treatments Advancements in laboratory serological assay Growing demand for point-of-care testing devices
Pitfalls & Challenges:	Strict regulatory regulations and the low detection rate of H. pylori infection

Learn more about the key segments shaping this market

Download Free Sample

Non-invasive helicobacter pylori testing refers to diagnostic methods used to detect the presence of H. pylori bacteria in the gastrointestinal tract without the need for invasive procedures such as endoscopy. These tests are designed to be simple, safe, and relatively comfortable for the patient, as they do not require the insertion of instruments into the body.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Non-invasive helicobacter pylori testing market size was USD 273.6 million in 2023 and is expected to register 7.1% CAGR from 2024-2032 owing to the rising prevalence of gastric and duodenal illnesses, such as gastric cancer and peptic ulcer disease, worldwide.

Non-invasive helicobacter pylori testing industry from the serologic test segment recorded USD 110.7 million in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to being convenient and preferable to patients.

North America non-invasive helicobacter pylori testing industry reached USD 97.7 million in 2023 and is expected to register a commendable CAGR from 2024-2032 due to favorable reimbursement policies and the region's higher healthcare expenditure.

Abbott, Biohit Oyj, Bio-Rad Laboratories, Inc., Cardinal Health, certest Biotech srl, Fisher Scientific, Gulf Coast Scientific, Meridian Bioscience Inc., Quidel Corporation, and Tri-Med, are some of the major non-invasive helicobacter pylori testing companies worldwide.